Pulmonx Corp (LUNG NASDAQ) stock market data APIs
$1.2698
0.07(5.5%)
as of April 7, 2026
Try our APIs with
free plan!
Pulmonx Corp Financial Data Overview
Price chart is built with
Anychart
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Prev. Close
1.2698
Open
1.3392
High
1.3629
Low
1.2674
52 wk Range
1.13-5.49
Market Cap
54 064 K
Shares Outstanding
42 237 K
Revenue
90 497 K
EPS
-0.25
Beta
0.188
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Pulmonx Corp (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pulmonx Corp data using free add-ons & libraries
Get Pulmonx Corp Fundamental Data
Pulmonx Corp Fundamental data includes:
- Net Revenue: 90 497 K
- EBITDA: -52 609 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-25
- EPS/Forecast: -0.3948
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pulmonx Corp News
New
Pulmonx Q4 Earnings Call Highlights
Pulmonx logo Key Points Management says U.S. underperformance in 2025 was driven by “internal operational and executional challenges,” including disruptive territory changes and incentive design...
Pulmonx (LUNG) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool. DATE Wednesday, March 4, 2026 at 4:30 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Glendon FrenchChief Operating Officer and Chief Financial O...
Pulmonx (LUNG) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool. DATE Wednesday, March 4, 2026 at 4:30 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Glendon French Chief Operating Officer and Chief Financial ...
Pulmonx GAAP EPS of -$0.25 beats by $0.14, revenue of $22.59M beats by $0.86M
* Pulmonx press release [https://seekingalpha.com/pr/20424659-pulmonx-reports-fourth-quarter-and-full-year-2025-financial-results] (LUNG [https://seekingalpha.com/symbol/LUNG]): Q4 GAAP EPS of -$0.2...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
